ArtVentive Medical Group signs development agreement with Medical Murray

NewsGuard 100/100 Score

ArtVentive Medical Group, Inc. (OTC Bulletin Board: AVTD) announced the Company has signed a manufacturing, research and development agreement with Medical Murray Inc. (ISO certified and FDA registered). Medical Murray is a leader in medical device and product development including specialty manufacturing services.

“We are pleased to have signed an agreement with such a world class organization.”

The agreement is projected to significantly reduce ArtVentive's development time to deliver products for clinical studies and commercialization. The first Endoluminal Occlusion Device (EOS) prototypes were produced prior to entering into the Agreement with Medical Murray to demonstrate the device's dimensional properties and functionality. The new series of functional prototypes comprise of a combination of an implant scaffold with a polymeric cover and a delivery catheter that has been under development for the upcoming series of animal studies.

"This arrangement will significantly enhance our ability to bring products to markets swiftly while maintaining tight controls on manufacturing, research and development" said Jim Graham, President, ArtVentive Medical Group, Inc, "We are pleased to have signed an agreement with such a world class organization."

SOURCE ArtVentive Medical Group, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer